Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 6/20 | 0.49 |
| ▸ | SRC | P12931 | 4/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.40 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24844368 | 0.81 | FGFR1 (0.40) | FGFR1SRCHTTALDH1A1 | |
| SCHEMBL17940706 | 0.80 | HTT (0.51) | FGFR1SRCHTT | |
| SCHEMBL17940746 | 0.78 | HPGD (0.41) | FGFR1SRCALDH1A1HPGD | |
| SCHEMBL17940747 | 0.77 | HPGD (0.48) | FGFR1ALDH1A1HPGD | |
| SCHEMBL17940732 | 0.73 | GABRA1 (0.49) | FGFR1SRCHTTALDH1A1 | |
| SCHEMBL29642847 | 0.73 | GABRA1 (0.49) | FGFR1SRCHTTALDH1A1 | |
| SCHEMBL17940725 | 0.73 | FGFR1 (0.59) | FGFR1SRCHTTALDH1A1HPGD | |
| SCHEMBL17940689 | 0.71 | CYP17A1 (0.39) | FGFR1SRCMAPK1 | |
| SCHEMBL17940726 | 0.70 | HCAR1 (0.41) | FGFR1ALDH1A1HPGDMAPK1 | |
| SCHEMBL13993884 | 0.69 | FGFR1 (0.76) | FGFR1SRCHTTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | FGFR1 2889/4885SRC 1034/4885HTT 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.